Mutant selection window and characterization of allelic diversity for ciprofloxacin-resistant mutants of Rhodococcus equi

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 8, 2010, Pages 3520-3523

  Niwa, Hidekazu ^a   Lasker, Brent A ^b  

^a EQUINE RESEARCH INSTITUTE   (Japan)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; ASPARTIC ACID; BACTERIAL ENZYME; CIPROFLOXACIN; CYSTEINE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; GLYCINE; HISTIDINE; ISOLEUCINE; SERINE;

ALLELE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; BACTERIUM ISOLATE; BACTERIUM MUTANT; CORRELATION ANALYSIS; DNA SEQUENCE; GENETIC VARIABILITY; MINIMUM INHIBITORY CONCENTRATION; MUTANT PREVENTION CONCENTRATION; MUTANT SELECTION WINDOW; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RHODOCOCCUS EQUI; RISK ASSESSMENT;

ALLELES; AMINO ACID SUBSTITUTION; ANIMALS; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; RHODOCOCCUS EQUI; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 77955408784     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01670-09     Document Type: Article

References (29)

1. Bowersock, T. L., S. A. Salmon, E. S. Portis, J. F. Prescott, D. A. Robison, C. W. Ford, and J. L. Watts. 2000. MICs of oxazolidinone for Rhodococcus equi strains isolated from humans and animals. Antimicrob. Agents Chemother. 44:1367-1369.
2. CLSI/NCCLS. 2003. Susceptibility testing for mycobacteria, nocardiae, and other aerobic actinomycetes. Approved standard M24-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
3. Cui, J., Y. Liu, R. Wang, W. Tong, K. Drlica, and X. Xhao. 2006. The mutant selection window in rabbits infected with Staphylococcus aureus. J. Infect. Dis. 194:1601-1608.
4. Dong, Y., X. Zhao, B. N. Kreiswirth, and K. Drlica. 2000. Mutant protection concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44:2581-2584.
5. Drlica, K. 2003. The mutant selection window and antimicrobial resistance. J. Antimicrob. Chemother. 52:11-17.
6. Drlica, K., and X. Zhao. 2007. Mutant selection window hypothesis updated. Clin. Infect. Dis. 44:681-688.
7. Firsov, A. A., S. N. Vostrov, I. Y. Lubenko, K. Drlica, Y. A. Portnoy, and S. H. Zinner. 2003. In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus. Antimicrob. Agents Chemother. 47:1604-1613.
8. Giguere, S., and J. F. Prescott. 1997. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet. Microbiol. 56:313-334.
9. Ginsburg, A. S., S. C. Woowine, N. Hooper, W. H. Benjamin, Jr., W. R. Bishai, S. E. Dorman, and T. R. Sterling. 2003. The rapid development of fluoroquinolone resistance in M. tuberculosis. N. Engl. J. Med. 349:1977-1978.
10. Guillemin, I., V. Jarlier, and E. Cambau. 1998. Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in Mycobacteria. Antimicrob. Agents Chemother. 42:2084-2088. (Pubitemid 28363097)
11. Hopkins, K. L., R. H. Davies, and E. J. Threlfall. 2005. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int. J. Antimicrob. Agents 25:358-373.
12. Hsueh, P. R., C. C. Hung, L. J. Teng, M. C. Yu, Y. C. Chen, H. K. Wang, and K. T. Luh. 1998. Report of invasive Rhodococcus equi infections in Taiwan, with an emphasis on the emergence of multidrug-resistant strains. Clin. Infect. Dis. 27:370-375.
13. Israel, D., G. Gillum, M. Turik, K. Harvey, J. Ford, H. Dalton, M. Towle, R. Echols, A. H. Heller, and R. Polk. 1993. Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers. Antimicrob. Agents Chemother. 37:2193-2199.
14. Magnusson, H. 1923. Spezifische infektiose Pneumonie beim Fohlen. Ein neuer Eiterreger beim Pferd. Arch. Wiss. Prakt. Tierhelkd. 50:22-28.
15. Reference deleted.
16. McNeil, M. M., and J. M. Brown. 1992. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens. Eur. J. Epidemiol. 8:437-443.
17. Moretti, F., E. Quiros-Roldan, S. Casari, P. Viale, A. Chiodera, and G. Carosi. 2002. Rhodococcus equi: pulmonary cavitation lesion in patient infected with HIV cured by levofloxacin and rifampicin. AIDS 16:1440-1442.
18. Mouneimne, H., J. Robert, V. Jarlier, and E. Cambau. 1999. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:62-66.
19. Munoz, P., J. Palomo, J. Guinea, J. Yanez, M. Giannella, and E. Bouza. 2008. Relapsing Rhodococcus equi infection in a heart transplant recipient successfully treated with long-term linezolid. Diagn. Microbiol. Infect. Dis. 60:197-199.
20. Niwa, H., S. Hobo, and T. Anzai. 2006. A nucleotide mutation associated with fluoroquinolone resistance observed in gyrA of in vitro obtained Rhodococcus equi mutants. Vet. Microbiol. 115:264-268. (Pubitemid 43766965)
21. Niwa, H., S. Hobo, T. Anzai, and T. Higuchi. 2005. Antimicrobial susceptibility of 616 Rhodococcus equi strains isolated from tracheobronchial aspirates of foals suffering from respiratory disease in Japan. J. Equine Sci. 16:99-104.
22. Nordmann, P., E. Rouveix, M. Guenounou, and M. H. Nicolas. 1992. Pulmonary abscess due to a rifampin and fluoroquinolone resistant Rhodococcus equi strain in a HIV infected patient. Eur. J. Clin. Microbiol. Infect. Dis. 11:557-558.
23. Perlman, D. C., W. M. El Sadr, L. B. Heifets, E. T. Nelson, J. P. Matts, K. Chirgwin, N. Salomon, E. E. Telzak, O. Klein, B. N. Kreiswirth, J. M. Musser, and R. Hafner for the Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol Team. 1997. Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. AIDS 11:1473-1478.
24. Prescott, J. F. 1991. Rhodococcus equi: an animal and human pathogen. Clin. Microbiol. Rev. 4:20-34.
25. Scotton, P. G., E. Tonon, M. Giobbia, M. Gallucci, R. Rigoli, and A. Vaglia. 2000. Rhodococcus equi nosocomial meningitis cured by levofloxacin and shunt removal. Clin. Infect. Dis. 30:223-224.
26. Van Bambeke, F., J. M. Michot, J. Van Eldere, and P. M. Tulkens. 2005. Quinolones in 2005: an update. Clin. Microbiol. Infect. 11:256-280.
27. Weinstock, D. M., and A. E. Brown. 2002. Rhodococcus equi: an emerging pathogen. Clin. Infect. Dis. 34:1379-1385.
28. Zhao, X., and K. Drlica. 2002. Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window. J. Infect. Dis. 185:561-565.
29. Zhou, J., Y. Dong, X. Zhao, S. Lee, A. Amin, S. Ramaswamy, J. Domagala, J. M. Musser, and K. Drlica. 2000. Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. J. Infect. Dis. 182:517-525.